Soleno Therapeutics Inc. (SLNO)
NASDAQ: SLNO
· Real-Time Price · USD
71.63
-5.73 (-7.41%)
At close: Aug 15, 2025, 3:59 PM
72.00
0.52%
After-hours: Aug 15, 2025, 07:57 PM EDT
Soleno Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 32.66M | n/a | n/a | 3.45M | 3.45M | 3.45M | 3.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 696K | 494K | 984K | 1.47M | 2.03M | 2.13M | 2.21M | 2.24M | 2.25M | 2.21M | 2.21M | 2.21M | 2.2M | 2.21M | 2.21M | 1.69M | 1.13M | 565K |
Gross Profit | 31.96M | -494K | -984K | 1.97M | 1.42M | 1.31M | 1.23M | -2.24M | -2.25M | -2.21M | -2.21M | -2.21M | -2.2M | -2.21M | -2.21M | -1.69M | -1.13M | -565K |
Operating Income | -191.6M | -208.3M | -183.96M | -137.67M | -68.32M | -53.71M | -40.78M | -33.56M | -28.94M | -27.09M | -12.85M | -10.24M | -12.29M | -16.6M | -13.22M | -18.17M | -17.74M | -17.85M |
Interest Income | 10.15M | 9.97M | 12.05M | 10.83M | 7.41M | 4.54M | 2.58M | 559K | 486K | 391K | 300K | 209K | 142K | 131K | 110K | 76K | 43K | 3K |
Pretax Income | -181.08M | -198.22M | -175.85M | -131.16M | -65.41M | -52.03M | -38.99M | -33.18M | -28.45M | -26.7M | -24.07M | -21.41M | -23.42M | -27.68M | -30.91M | -30.93M | -31.34M | -27.73M |
Net Income | -181.08M | -198.22M | -175.85M | -131.16M | -65.41M | -52.03M | -38.98M | -31.43M | -26.86M | -26.24M | -21.8M | -20.88M | -22.73M | -25.87M | -30.91M | -30.93M | -31.34M | -27.73M |
Selling & General & Admin | 144M | 126.15M | 105.37M | 71.72M | 25.84M | 18.61M | 12.99M | 11.74M | 10.76M | 10.05M | 9.84M | 10.04M | 10.47M | 10.47M | 10.81M | 10.46M | 9.95M | 9.73M |
Research & Development | 74.29M | 77.48M | 78.57M | 65.77M | 41.68M | 34.48M | 25.19M | 20.31M | 18.04M | 16.59M | 15.27M | 15.19M | 16.39M | 18.28M | 21.45M | 23.29M | 23.14M | 23.66M |
Other Expenses | 5.27M | 4.17M | 1.6M | 1.28M | 1.42M | 1.74M | 1.63M | 1.5M | 612K | 915K | 616K | 748K | 1.17M | 3.58M | 3.58M | 3.58M | 3.03M | n/a |
Operating Expenses | 223.56M | 207.81M | 185.54M | 138.76M | 68.93M | 54.51M | 39.2M | 33.07M | 28.8M | 26.65M | 25.11M | 25.23M | 26.86M | 28.75M | 32.26M | 33.75M | 33.09M | 33.39M |
Interest Expense | 246K | -1.13M | 231K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -494K | -494K | -983K | -983K | -489K | -489K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 225.4M | 209.45M | 187.19M | 139.75M | 69.92M | 55M | 39.69M | 33.07M | 28.8M | 26.65M | 25.11M | 25.23M | 26.86M | 28.75M | 32.26M | 33.75M | 33.09M | 33.39M |
Income Tax Expense | n/a | n/a | 1.19M | 3.19M | 1.03M | 1.03M | -165K | -3.91M | -1.59M | -463K | -2.27M | -531K | -690K | -1.81M | -1.19M | -1.19M | -1.19M | -1.19M |
Shares Outstanding (Basic) | 50.48M | 46.18M | 43.92M | 41.88M | 38.63M | 36.21M | 34.39M | 11.43M | 10.42M | 9.45M | 9.44M | 9.42M | 9.34M | 5.33M | 5.32M | 5.32M | 5.32M | 5.31M |
Shares Outstanding (Diluted) | 50.48M | 46.18M | 43.92M | 41.88M | 38.63M | 36.21M | 34.44M | 11.44M | 10.42M | 9.45M | 9.44M | 9.42M | 9.34M | 5.33M | 5.32M | 5.32M | 5.32M | 5.31M |
EPS (Basic) | -4.14 | -4.62 | -4.26 | -3.32 | -2.44 | -2.68 | -2.97 | -3.04 | -2.76 | -2.79 | -2.64 | -2.77 | -3.63 | -4.86 | -5.82 | -5.83 | -5.91 | -6.24 |
EPS (Diluted) | -4.14 | -4.62 | -4.26 | -3.32 | -2.44 | -2.68 | -2.97 | -3.04 | -2.76 | -2.79 | -2.64 | -2.77 | -3.63 | -4.86 | -5.82 | -5.83 | -5.91 | -6.24 |
EBITDA | -178.82M | -198.73M | -179.4M | -136.5M | -66.53M | -51.67M | -36.77M | -30.15M | -26.85M | -24.64M | -23.1M | -23.21M | -24.89M | -26.78M | -30.3M | -31.79M | -31.14M | -31.44M |
EBIT | -180.83M | -200.73M | -181.39M | -138.47M | -68.5M | -53.57M | -38.86M | -32.24M | -28.98M | -26.83M | -25.11M | -25.23M | -26.86M | -28.75M | -32.26M | -33.75M | -33.09M | -33.39M |
Depreciation & Amortization | 2.01M | 2M | 1.99M | 1.97M | 2.03M | 2.13M | 2.21M | 2.24M | 2.25M | 2.21M | 2.21M | 2.21M | 2.2M | 2.21M | 2.21M | 2.18M | 2.11M | 2.03M |